Redeye: Alelion Q2 2023 - Slowly digesting that SEK350m order backlog
Redeye updates its estimates following Alelion’s Q2 2023 report, which was largely in line with our expectations. Deliveries are still hampered by component shortages, thus postponing the sales curve and the conversion of the SEK350m order backlog. Furthermore, Alelion is in the process of releasing its next generation battery system, which lays the groundwork for new order intake in 2024.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/